PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients

CompletedOBSERVATIONAL
Enrollment

1,376

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Prostate CancerObesity
Trial Locations (34)

Unknown

Research Site, Baja

Research Site, Barcs

Research Site, Békés

Research Site, Békéscsaba

Research Site, Budapest

Research Site, Csongrád

Research Site, Debrecen

Research Site, Dunaharaszti

Research Site, Dunaújváros

Research Site, Győr

Research Site, Gyula

Research Site, Helvécia

Research Site, Jászberény

Research Site, Kaposvár

Research Site, Kecskemét

Research Site, Kiskunhalas

Research Site, Kőszárhegy

Research Site, Makó

Research Site, Miskolc

Research Site, Nagyvenyim

Research Site, Nyíregyháza

Research Site, Nyírpazony

Research Site, Orosháza

Research Site, Pápa

Research Site, Pécs

Research Site, Salgótarján

Research Site, Szeged

Research Site, Szekszárd

Research Site, Szentendre

Research Site, Székesfehérvár

Research Site, Szolnok

Research Site, Szombathely

Research Site, Tiszaföldvár

Research Site, Veszprém

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY